Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-β-carboline)-3-carboxamides

Biomedicine and Pharmacotherapy

Volumn 64, Issue 6, 2010, Pages 386-389

  Tonin, Lilian T Düsman ^a   Panice, Manuela Ribeiro ^a   Nakamura, Celso Vataru ^a   Rocha, Karin Juliane Pelizzaro ^a   Santos, Adriana Oliveira dos ^a   Ueda Nakamura, Tânia ^a   Costa, Willian Ferreira da ^a   Sarragiotto, Maria Helena ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Leishmania amazonensis; N alkyl(1 phenylsubstituted carboline) 3 carboxamides; Trypanosoma cruzi

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CARBOLINE DERIVATIVE; N BUTYL [1 (2 CHLORO)PHENYL 9H BETA CARBOLINE] 3 CARBOXAMIDE; N BUTYL [1 (4 METHOXY)PHENYL 9H BETA CARBOLINE] 3 CARBOXAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CHAGAS DISEASE; DRUG INDICATION; DRUG SELECTIVITY; DRUG SYNTHESIS; EPIMASTIGOTE; LEISHMANIA; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; TRYPANOSOMA CRUZI;

ANIMALS; CARBOLINES; LEISHMANIA MEXICANA; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 77954309552     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.02.006     Document Type: Article

References (24)

1. World Health Organization. http://www.who.int/tdr/diseases/chagas/, accessed in November 05, 2007.
2. Sereno D., Silva A.C., Mathieu-Daude F., Ouaissi A. Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int 2007, 56:3-7.
3. Moncayo A. Tropical Disease Research Progress 1991 e 1992, WHO. Geneva 1993.
4. Maya J.D., Cassels B.K., Iturriaga-Vásquez P., Ferreira F., Faúndez M., Galanti N., et al. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A, Mol Integr Physiol 2007, 146:601-620.
5. World Health Organization. http://www.who.int/we, accessed in January 10, 2008.
6. Paris C., Loiseau P.M., Bories C., Bréard J. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2004, 48:852-859.
7. Alnaim L., Alsoud N.A., Zaghloul I., AL-Jaser M. Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters. Int J Antimicrob Agents 2007, 29:728-732.
8. Davis A.J., Murray H.W., Handman E. Drugs against leishmaniasis: a synergy of technology and partnerships. Trends Parasitol 2004, 20:73-76.
9. Croft S.L., Seifert K., Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006, 123:399-410.
10. McConville M.J., Handman E. The molecular basis of Leishmania pathogenesis. Int J Parasitol 2007, 37:1047-1051.
11. Cavin J.C., Krassner S.M., Rodriguez E. Plant-derived alkaloids active against Trypanosoma cruzi. J Ethnopharmacol 1987, 19:89-94.
12. Rivas P., Cassels B.K., Morello A., Repetto Y. Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes. Comp Biochem Physiol 1999, 122:27-31.
13. Ferreira M.E., Nakayama H., de Arias A.R., Schinini A., de Bilbao N.V., Serna E., et al. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice. J Ethnopharmacol 2007, 109:258-263.
14. Boursereau Y., Coldham I. Synthesis and biological studies of 1-amino beta-carbolines. Bioorg Med Chem Lett 1 2004, 14:5841-5844.
15. Barbaras D., Kaiser M., Brun R., Gademann K. Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimmers. Bioorg Med Chem Lett 2008, 28:4413-4415.
16. Di Giorgio C., Delmas F., Ollivier E., Elias R., Balansard G., David P.T. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol 2004, 106:67-74.
17. Ferreira M.E., de Arias A.R., de Ortiz S.T., Inchausti A., Nakayama H., Thouvenel C., et al. Leishmanicidal activity of two canthin-6-one alkaloids, two major constituents of Zanthoxylum chiloperone var. angustifolium. J Ethnopharmacol 2002, 80:199-202.
18. Dodd R.H., Ouannes C., Robert-Géro M., Potier P. Hybrid molecules - growth-inhibition of Leishmania donovani promastigotes by thiosemicarbazones of 3-carboxy-beta-carbolines. J Med Chem 1989, 32:1272-1276.
19. Jaisankar P., Pal B., Manna R.K., PradhanPK, Medda S., Basu M.K., et al. Synthesis of antileishmanial (5R)-(-)-5-carbomethoxy-3-formyl-5,6-dihydroindolo-[2,3-a]-indolizine. Arkivoc 2003, 150-157.
20. Kumar A., Katiyar S.B., Gupta S., Chauhan P.M.S. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents. Eur J Med Chem 2006, 41:106-113.
21. Costa E.V., Pinheiro M.L.B., Xavier C.M., Silva J.R.A., Amaral A.C.F., Souza A.D.L., et al. A pyrimidine-beta-carboline and other alkaloids from Annona foetida with antileishmanial activity. J Nat Prod 2006, 69:292-294.
22. Tonin L.T.D., Barbosa V.A., Bocca C.C., Ramos E.R.F., Nakamura C.V., da Costa W.F., et al. Comparative study of the trypanocidal activity of the methyl 1-nitrophenyl-1,2,3,4-9H-tetrahydro-beta-carboline-3-carboxylate derivatives and benznidazole using theoretical calculations and cyclic voltammetry. Eur J Med Chem 2009, 44:1745-1750.
23. Valdez R.H., Tonin L.T.D., Ueda-Nakamura T., Dias Filho B.P., Morgado-Diaz J.A., Sarragiotto M.H., et al. Biological activity of 1,2,3,4-tetrahydro-beta-carboline-3-carboxamides against Trypanosoma cruzi. Acta Trop 2009, 110:7-14.
24. Formagio A.S.N., Tonin L.T.D., Foglio M.A., Madjarof C., de Carvalho J.E., da Costa W.F., et al. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives. Bioorg Med Chem 2008, 16:9660-9667.